ReShape Lifesciences Inc (RSLS) concluded trading on Wednesday at a closing price of $1.36, with 37.49 million shares of worth about $50.99 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -86.92% during that period and on February 19, 2025 the price saw a gain of about 25.93%. Currently the company’s common shares owned by public are about 0.70M shares, out of which, 0.69M shares are available for trading.
Stock saw a price change of -49.72% in past 5 days and over the past one month there was a price change of -69.91%. Year-to-date (YTD), RSLS shares are showing a performance of -69.51% which decreased to -86.38% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.01 but also hit the highest price of $29.00 during that period. The average intraday trading volume for ReShape Lifesciences Inc shares is 159.17K. The stock is currently trading -57.95% below its 20-day simple moving average (SMA20), while that difference is down -66.77% for SMA50 and it goes to -82.70% lower than SMA200.
ReShape Lifesciences Inc (NASDAQ: RSLS) currently have 0.70M outstanding shares and institutions hold larger chunk of about 4.09% of that.
The stock has a current market capitalization of $0.99M and its 3Y-monthly beta is at 1.44. It has posted earnings per share of -$16.40 in the same period. It has Quick Ratio of 0.60 while making debt-to-equity ratio of 0.13. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for RSLS, volatility over the week remained 22.16% while standing at 12.73% over the month.
